Alain Bernard Labrique

Alain Bernard Labrique

Auto-generated profile, based on publicly available information

Alain Bernard Labrique

Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2016 in BMJ
Verified
Journal Article
Closed access
PDF file
SASmisha Agarwal
Smisha Agarwal
ALAmnesty E LeFevre
Amnesty E LeFevre
JLJaime Lee
Jaime Lee
KLKelly L’engle
Kelly L’engle
GMGarrett Mehl
Garrett Mehl
ALAlain Labrique
Alain Labrique
To improve the completeness of reporting of mobile health (mHealth) interventions, the WHO mHealth Technical Evidence Review Group developed the mHealth evidence reporting and assessment (mERA) checklist. The development process for mERA consisted of convening an expert group to recommend an appropriate approach, convening a global expert review panel for checklist development, and pilot testing the checklist. The guiding principle for the development of these criteria was to identify a minimum set of information needed to define what the mHealth intervention is (content), where it is being implemented (context), and how it was implemented (technical features), to support replication of the intervention. This paper presents the resulting 16 item checklist and a detailed explanation and elaboration for each item, with illustrative reporting examples. Through widespread adoption, we expect that the use of these guidelines will standardise the quality of mHealth evidence reporting, and indirectly improve the quality of mHealth evidence.

14 May 2015 in Tropical Medicine & International Health
Verified
Journal Article
Open access
PDF file
SASmisha Agarwal
Smisha Agarwal
HPHenry B. Perry
Henry B. Perry
LLLesley‐Anne Long
Lesley‐Anne Long
ALAlain B. Labrique
Alain B. Labrique
Objectives: Given the large‐scale adoption and deployment of mobile phones by health services and frontline health workers (FHW), we aimed to review and synthesise the evidence on the feasibility and effectiveness of mobile‐based services for healthcare delivery.Methods: Five databases – MEDLINE, EMBASE, Global Health, Google Scholar and Scopus – were systematically searched for relevant peer‐reviewed articles published between 2000 and 2013. Data were extracted and synthesised across three themes as follows: feasibility of use of mobile tools by FHWs, training required for adoption of mobile tools and effectiveness of such interventions.Results: Forty‐two studies were included in this review. With adequate training, FHWs were able to use mobile phones to enhance various aspects of their work activities. Training of FHWs to use mobile phones for healthcare delivery ranged from a few hours to about 1 week. Five key thematic areas for the use of mobile phones by FHWs were identified as follows: data collection and reporting, training and decision support, emergency referrals, work planning through alerts and reminders, and improved supervision of and communication between healthcare workers. Findings suggest that mobile based data collection improves promptness of data collection, reduces error rates and improves data completeness. Two methodologically robust studies suggest that regular access to health information via SMS or mobile‐based decision‐support systems may improve the adherence of the FHWs to treatment algorithms. The evidence on the effectiveness of the other approaches was largely descriptive and inconclusive.Conclusions: Use of mHealth strategies by FHWs might offer some promising approaches to improving healthcare delivery; however, the evidence on the effectiveness of such strategies on healthcare outcomes is insufficient.

3 November 2018 in Globalization and Health
Verified
Journal Article
Open access
PDF file
ALAlain B. Labrique
Alain B. Labrique
CWChristina Wadhwani
Christina Wadhwani
KWKoku Awoonor Williams
Koku Awoonor Williams
PLPeter Lamptey
Peter Lamptey
CHCees Hesp
Cees Hesp
AAAnn Aerts
Ann Aerts
Healthcare challenges in low and middle income countries (LMICs) have been the focus of many digital initiatives that have aimed to improve both access to healthcare and the quality of healthcare delivery. Moving beyond the initial phase of piloting and experimentation, these initiatives are now more clearly focused on the need for effective scaling and integration to provide sustainable benefit to healthcare systems. Based on real-life case studies of scaling digital health in LMICs, five key focus areas have been identified as being critical for success. Firstly, the intrinsic characteristics of the programme or initiative must offer tangible benefits to address an unmet need, with end-user input from the outset. Secondly, all stakeholders must be engaged, trained and motivated to implement a new initiative, and thirdly, the technical profile of the initiative should be driven by simplicity, interoperability and adaptability. The fourth focus area is the policy environment in which the digital healthcare initiative is intended to function, where alignment with broader healthcare policy is essential, as is sustainable funding that will support long-term growth, including private sector funding where appropriate. Finally, the extrinsic ecosystem should be considered, including the presence of the appropriate infrastructure to support the use of digital initiatives at scale. At the global level, collaborative efforts towards a less-siloed approach to scaling and integrating digital health may provide the necessary leadership to enable innovative solutions to reach healthcare workers and patients in LMICs. This review provides insights into best practice for scaling digital health initiatives in LMICs derived from practical experience in real-life case studies, discussing how these may influence the development and implementation of health programmes in the future.

16 April 2020 in JMIR Public Health and Surveillance
Verified
Journal Article
Open access
SMSultan Mahmood
Sultan Mahmood
KHKhaled Hasan
Khaled Hasan
MCMichelle Colder Carras
Michelle Colder Carras
ALAlain Labrique
Alain Labrique
The coronavirus disease (COVID-19) pandemic has revealed many areas of public health preparedness that are lacking, especially in lower- and middle-income countries. Digital interventions provide many opportunities for strengthening health systems and could be vital resources in the current public health emergency. We provide several use cases for infection control, home-based diagnosis and screening, empowerment through information, public health surveillance and epidemiology, and leveraging crowd-sourced data. A thoughtful, concerted effort—leveraging existing experience and robust enterprise-grade technologies—can have a substantive impact on the immediate and distal consequences of COVID-19.

5 May 2017 in Journal of Medical Internet Research
Verified
Journal Article
Open access
DGDustin G Gibson
Dustin G Gibson
APAmanda Pereira
Amanda Pereira
BFBrooke Farrenkopf
Brooke Farrenkopf
ALAlain B Labrique
Alain B Labrique
GPGeorge W Pariyo
George W Pariyo
AHAdnan A Hyder
Adnan A Hyder
Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet

1 January 2014 in Clinical Microbiology Reviews
Verified
Journal Article
Open access
PDF file
LKLisa J. Krain
Lisa J. Krain
KNKenrad E. Nelson
Kenrad E. Nelson
ALAlain B. Labrique
Alain B. Labrique
SUMMARY Hepatitis E virus (HEV), identified over 30 years ago, remains a serious threat to life, health, and productivity in developing countries where access to clean water is limited. Recognition that HEV also circulates as a zoonotic and food-borne pathogen in developed countries is more recent. Even without treatment, most cases of HEV-related acute viral hepatitis (with or without jaundice) resolve within 1 to 2 months. However, HEV sometimes leads to acute liver failure, chronic infection, or extrahepatic symptoms. The mechanisms of pathogenesis appear to be substantially immune mediated. This review covers the epidemiology of HEV infection worldwide, the humoral and cellular immune responses to HEV, and the persistence and protection of antibodies produced in response to both natural infection and vaccines. We focus on the contributions of altered immune states (associated with pregnancy, human immunodeficiency virus [HIV], and immunosuppressive agents used in cancer and transplant medicine) to the elevated risks of chronic infection (in immunosuppressed/immunocompromised patients) and acute liver failure and mortality (among pregnant women). We conclude by discussing outstanding questions about the immune response to HEV and interactions with hormones and comorbid conditions. These questions take on heightened importance now that a vaccine is available.